The most-searched fund category Europeans cannot actually buy: a Magnificent 7 ETF. The famous American instrument — Roundhill’s MAGS, equal-weighting Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta and Tesla at 0.30% — is PRIIPs-blocked for EU retail investors, and as of this writing no plain UCITS equivalent exists. The hundreds of searches this site collects on “mag 7 etf” deserve that answer stated plainly before anything else, because half the internet’s results pretend otherwise.
What Europe actually offers: index funds whose concentration already delivers most of the Mag-7 story, single-stock routes that replicate it exactly, and leveraged products that abuse it. This guide compares them honestly — including the question the searches skip: whether concentrating further into seven names your portfolio already owns heavily is a plan or a mood. Verified August 2026.
The routes at a glance
| Route | Mag-7 exposure | Cost | Verdict |
|---|---|---|---|
| CNDX / Nasdaq-100 | ~40%+ of the fund | 0.30–0.33% | The practical default |
| IITU / S&P tech sector | Tech five heavily, capped | 0.15% | The concentrated tech tier |
| Seven single-stock savings plans | 100%, your weights | ~free at neo-brokers | The exact replication |
| Leveraged Mag-7 ETPs | Amplified daily | High + decay | Trading tools, not holdings |
| US MAGS via loopholes | Equal-weight 7 | Blocked / professional-only | Not a retail plan |
Comparing funds is step one — the Masterclass turns it into a complete plan — fund choice, broker setup, YOUR country’s taxes and the first purchase, in 55 text lessons.
See the full curriculum — €147, 30-day guarantee →Why there’s no UCITS Mag-7 ETF
Two structural reasons, worth knowing because they explain the whole shelf. Diversification rules: UCITS caps single positions — the 5/10/40 framework — making a seven-stock equal-weight fund essentially impossible to run as a standard UCITS ETF; the US wrapper faces no such constraint. PRIIPs: the US fund publishes no EU key-information document, so European retail platforms cannot sell it — the same wall that blocks SPY and every American ETF. The result: the cleanest version of the trade is regulatorily homeless in Europe, and everything sold as “Mag-7 exposure” here is either an index fund with concentration, a derivative product, or a portfolio of the seven stocks held directly. That’s not a tragedy — it’s a menu, and the menu has a rational order.
For the bigger picture, start with our ETF comparison hub.
Route one: the index funds you probably already hold
The under-appreciated fact in every “mag 7 etf” search: a Nasdaq-100 fund is already most of the trade. The seven names dominate CNDX’s weight; the index’s remaining tail is itself mega-tech-adjacent; and the wrapper adds UCITS protections, Irish tax treatment and savings-plan automation the US product never could. IITU concentrates differently — the S&P tech sector holds the tech five at capped weights without Amazon/Alphabet/Meta (GICS files them elsewhere) at a cheaper 0.15%. And every S&P 500 fund runs a third of its weight in the seven already. The practical conclusion: before buying any Mag-7 product, audit what your existing wrappers already hold — most European portfolios discover they own the trade two or three times over, which reframes the search entirely: the question isn’t how to get exposure; it’s whether to concentrate what you have.
Route two: the seven stocks, directly
The exact replication needs no fund: European neo-brokers run free savings plans on all seven names, fractional shares make any budget work, and seven positions rebalanced yearly is one evening of administration. The honest accounting: you’ll hold US stocks directly (W-8BEN form, 15% dividend withholding — trivial for these near-zero-yield names), you lose UCITS wrapper conveniences, and you gain exact control of weights — equal-weight like MAGS, or conviction-weighted as you prefer. For investors who genuinely want the seven-name bet and nothing else, this route is cheaper and cleaner than any product — the fund industry simply can’t say so.
Route three: the products to avoid
The search’s dangerous neighborhood: leveraged single-stock and basket ETPs marketed on Mag-7 branding — 2x and 3x daily-reset instruments whose volatility decay converts sideways markets into losses regardless of direction. The futures guide’s logic applies doubled: daily-reset leverage is a trading tool with a holding period measured in days, and every “buy and hold the 3x” story ends in the same chart. Retail platforms also occasionally surface professional-only US fund access via complex routes — if a workaround requires reclassifying yourself, the workaround is the warning.
The question underneath: should you concentrate at all?
The honest frame this site owes readers: the Mag-7 already dominate every cap-weighted portfolio — a world fund holds them at nearly a fifth of everything, an S&P fund at a third, CNDX at nearly half. Concentrating further is a momentum bet on the decade’s winners continuing — historically the exact bet each era’s “obvious seven” eventually lost (the Nifty Fifty, the dot-com generals, the 2007 banks). It can keep paying; the AI capex cycle is real and the seven own it. But sized honestly it’s a satellite conviction — 5–10% beyond existing index weight at most — not a portfolio design. Investors who read that paragraph and still want the trade have three clean routes above; investors who read it and hesitate just saved themselves the concentration they already owned.
Reader scenarios
“Just tell me the closest thing to MAGS I can actually buy.” Seven single-stock savings plans, equal-weighted, rebalanced yearly — functionally identical, cheaper, and fully retail-legal. CNDX if you want one ticker and accept the index tail.
“Is there really no UCITS product coming?” Issuers file concentrated-basket products periodically and the UCITS caps keep the pure version off the shelf; watch for “top tech” funds that approximate it within the rules — and read their actual weights before believing the branding.
“Mag 7 vs just more CNDX?” CNDX is the diluted version of the trade — the marginal difference is the index’s non-Mag tail. If that tail bothers you, the single-stock route exists; if it doesn’t, you were done before you searched.
“What about equal-weight versus cap-weight for the seven?” Equal-weight triples the smaller names’ influence (Tesla especially) versus cap-weight’s Nvidia-Microsoft dominance — a real difference in any given year. MAGS chose equal; your savings plans can choose either; know which bet you’re making.
The audit-first habit this guide keeps prescribing is transferable: run the same top-ten overlap check before any thematic purchase on this site’s shelves, and half the products stop needing to be bought at all — the concentration was already there, waiting to be noticed.
Quick-start checklist
- Audit existing Mag-7 weight across every fund you hold — most portfolios own the trade already.
- Concentrating anyway? Pick the route: CNDX (one ticker), single stocks (exact), never leveraged ETPs.
- Cap the deliberate overweight at 5–10% beyond index weight.
- W-8BEN at your broker for the direct route.
- Annual review: the concentration number, and whether the thesis survived the year.
Verdict
There is no Magnificent 7 UCITS ETF, and Europeans lose almost nothing by it: the index funds already deliver the concentration, the single-stock route replicates the American product exactly for less, and the products filling the branding gap are mostly instruments this site exists to warn about. The search’s real answer is an audit, not a purchase — find out how much Mag-7 you already own, decide deliberately whether that’s enough, and let the routes above execute whatever you decide without paying anyone for the magnificent branding.
The seven, individually: what each actually is as a holding
The basket branding obscures seven very different businesses, and concentrators should know which they’re actually betting on. Microsoft and Apple: the cash-machine duopoly — platform economics, fortress balance sheets, the basket’s ballast. Alphabet and Meta: the advertising pair — extraordinary margins attached to one revenue source each, with AI both their weapon and their disruption risk. Amazon: the margin-transformation story — retail’s scale monetized through cloud and logistics. Nvidia: the pure AI-capex play — the basket’s torque, priced for the buildout’s continuation, the single largest source of any Mag-7 product’s volatility. Tesla: the outlier — an auto-and-robotics narrative stock whose weight in equal-weight baskets triples its influence versus cap-weighting. The practical read: an equal-weight seven is really a bet that Nvidia’s cycle holds and Tesla’s narrative revives; a cap-weight seven is mostly Microsoft-Apple-Nvidia with passengers. Neither is wrong — but “the Mag 7” is a media label, not a strategy, and the weights are the actual decision.
Reader scenarios, continued
“What breaks the Mag-7 trade?” The historical enders of concentration eras: regulation (antitrust remedies that split economics), capex disappointment (AI spending pausing before returns arrive), and succession of leadership (every prior era’s generals eventually ceded to a new cohort). None is forecastable; all are why the 5–10% overweight cap exists.
“Should I just wait for the UCITS product to launch?” The single-stock route already replicates it exactly — waiting for a wrapper adds nothing but delay and a future TER. If the trade convinces you, the menu is open today.
The concentration question in one honest paragraph
Every generation’s market produces an “obvious” cohort whose dominance feels permanent — and every prior cohort’s dominance ended while its obviousness peaked. That history doesn’t forbid the Mag-7 trade; it prices it: the seven are extraordinary businesses at extraordinary expectations, your index funds already own them at full market weight, and the marginal euro of deliberate concentration is a momentum bet whose asymmetry worsens as consensus completes. The routes this guide maps execute the bet cleanly for those who’ve sized it honestly — and the audit it prescribes rescues everyone else from making it by accident, which the searches suggest is the more common condition.
The mechanical antidote: the audit’s cleanest remedy — the same five hundred names with the concentration deleted by arithmetic — is reviewed in the S&P 500 Equal Weight (XDEW) guide.
The other famous-name wall: the SpaceX ETF that doesn’t exist — why, the traps, and the routes that work — gets the same honest treatment in the SpaceX guide.
Before adding more of the same: the sector-fund route to US technology, and the overlap arithmetic that makes it dangerous, is set out in the US tech sector guide.
Frequently asked questions
What are the Magnificent 7 stocks?
Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta and Tesla — the mega-cap cohort that has driven US index returns through the AI era; the label dates from 2023.
Why can’t Europeans buy the MAGS ETF?
PRIIPs rules require an EU key-information document US funds don’t produce — the same barrier blocking SPY and all American ETFs from EU retail platforms.
Could a UCITS fund hold just seven stocks?
Not under the standard 5/10/40 diversification caps — concentrated baskets reach Europe as ETPs/certificates instead, with different protections and cost structures.
How much Mag-7 is in a normal world ETF?
Roughly a fifth of the entire developed world’s weight — the concentration reaches you automatically; check any fund page’s top-ten for the live number.
Are the leveraged Mag-7 ETPs regulated?
They’re legal, listed instruments — regulation doesn’t repeal daily-reset decay; the products are built for day traders and priced accordingly.
Is equal-weighting the seven better than cap-weighting?
Different, not better — equal-weight amplifies the smaller members’ swings and rebalances into laggards quarterly; cap-weight rides the winners. Pick the philosophy consciously.
Do any European brokers offer Mag-7 baskets or certificates?
Structured certificates and basket products appear periodically — issuer credit risk and costs attach; the seven savings plans replicate the same exposure without either. Read any certificate’s fee stack before preferring it.
How much of the Nasdaq-100’s return came from the Mag 7?
In the AI-era years, the overwhelming majority — the index’s tail contributed single-digit shares of gains in the strongest years. CNDX is the trade with modest dilution, which is exactly why it’s the practical default.
What is a W-8BEN and do I need one?
The US tax form reducing dividend withholding to the 15% treaty rate for direct stockholders — brokers handle it digitally in minutes; without it you’d forfeit 30%. Required once, renewed every three years.
Cited sources: Roundhill MAGS fund data, iShares fund data, and ESMA PRIIPs framework. Verify current fund figures before investing. Educational content, not financial advice.
European UCITS/ETF investor with 11+ years building a global dividend and index portfolio, and founder of Financial Expert Class. I write every guide here from first-hand experience investing across EU brokers and tax regimes — not theory. More about me →